Press Resease

Cartilage Repair/Regeneration Market - Global Industry Analysis

Cartilage Repair/Regeneration Market by Treatment Modality (Cell Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis & Forecast, 2017 - 2024

Published Date: 14-Aug-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-2042 Status : Published

Global cartilage repair/regeneration market expected to generate revenue of around USD 6.5 billion by end of 2024, growing at a CAGR of around 5.8% between 2018 and 2024. The primary factor driving the global cartilage repair/regeneration market is the growing prevalence of joints & bones disorders all across the globe.

Description

The report covers forecast and analysis for the cartilage repair/regeneration market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the cartilage repair/regeneration market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cartilage repair/regeneration market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the cartilage repair/regeneration market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein by treatment modality, type, treatment, end use, and by region the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Cartilage Repair Regeneration Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the cartilage repair/regeneration market by segmenting the market based on by treatment modality, by type, by treatment, by end use, and by region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

Based on treatment modality, cartilage repair/regeneration market has been segmented into cell-based and non-cell based. The cell-based segment is sub-segmented into growth factor technology, chondrocyte transplantation, and stem cells and the non-cell based segment is sub-segmented into cell-free composites, tissue scaffolds, and stem cells. By treatment modality, cell-based treatment is estimated to hold the largest market value share attributed to the fact of long-term & effective results.

On the basis of treatment, cartilage repair/regeneration market has been segmented into cartilage replacement and cartilage repair. The cartilage replacement segment is sub-segmented into autologous chondrocyte implantation and osteochondral transplant and the cartilage repair segment is sub-segmented into cell-based cartilage resurfacing, microfracture, and non-surgical treatment.

By type segment, cartilage repair/regeneration market is bifurcated into fibrocartilage, hyaline cartilage, and elastic cartilage. 
Based on end use, cartilage repair/regeneration market is classified ambulatory surgical centers, surgical centers, hospitals and clinics, and others. Hospital & clinics segment held the maximum share and is expected to boost the market over the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries which include the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil.

The report also includes detailed profiles of end players such as include Osiris Therapeutics, Inc., Smith & Nephew Plc, Vericel Corporation, Depuy Synthes, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Anika Therapeutics S. R. L, Conmed Linvatec, RTI Surgical, Arthrex, Inc., and others. 

This report segments the global cartilage repair/regeneration market as follows:

Global Cartilage Repair/Regeneration Market: By Treatment Modality

  • Cell-Based
    • Growth Factor Technology
      • TGFs
      • BMPs
      • PDGF
      • IGF-1
    • Chondrocyte Transplantation
    • Stem Cells
  • Non-Cell Based
    • Cell-Free Composites
    • Tissue Scaffolds
    • Stem Cells

Global Cartilage Repair/Regeneration Market: By Type

  • Fibro Cartilage
  • Hyaline Cartilage    
  • Elastic Cartilage

Global Cartilage Repair/Regeneration Market: By Treatment

  • Cartilage Replacement
    • Autologous Chondrocyte Implantation
    • Osteochondral Transplant
  • Cartilage Repair
    • Cell-based Cartilage Resurfacing
    • Microfracture
    • Non-Surgical Treatment
      • Steroid Injections
      • Physical Therapy

Global Cartilage Repair/Regeneration Market: By End-Use

  • Ambulatory Surgical Centers
  • Hospitals & Clinics
  • Surgical Centers
  • Others 

Global Cartilage Repair/Regeneration Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Cartilage repair/regeneration market, 2015 - 2024 (USD Billion)
    • 2.2. Global Cartilage repair/regeneration market : Snapshot
  •  
  • Chapter 3. Cartilage Repair/Regeneration Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global cartilage repair/regeneration market drivers: Impact analysis
      • 3.2.2. Increasing joints & bones disorder
      • 3.2.3. Growing geriatric population anticipated to fuel the demand of Cartilage repair/regeneration market
      • 3.2.4. The market is expected to witness lucrative growth over the forecast period, owing to number of accident based injuries
      • 3.2.5. Increasing prevalence of sport injury
      • 3.2.6. Obese population due to the eating disorders
      • 3.2.7. Global cartilage repair/regeneration market restraints: Impact analysis
      • 3.2.8. High cost of the repair treatment
    • 3.3. Opportunities
      • 3.3.1. Increasing awareness among the population base regarding cartilage repair/regeneration market
    • 3.4. Porter's five forces analysis
      • 3.4.1. Bargaining power of suppliers
      • 3.4.2. Bargaining power of buyers
      • 3.4.3. Threat from new entrants
      • 3.4.4. Threat from new substitutes
      • 3.4.5. Degree of competition
    • 3.5. Market attractiveness analysis
      • 3.5.1. Market attractiveness analysis, by treatment modality segment
      • 3.5.2. Market attractiveness analysis, by type segment
      • 3.5.3. Market attractiveness analysis, by treatment segment
      • 3.5.4. Market attractiveness analysis, by end-user type segment
      • 3.5.5. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Cartilage Repair/Regeneration Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global cartilage repair/regeneration market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Cartilage Repair/Regeneration Market - Treatment Modality Analysis
    • 5.1. Global cartilage repair/regeneration market: by treatment modality overview
      • 5.1.1. Global cartilage repair/regeneration market revenue share, by treatment modality, 2018 and 2024
    • 5.2. Cell-Based
      • 5.2.1. Global cartilage repair/regeneration market for cell-based, 2015 - 2024 (USD Billion)
    • 5.3. Non-Cell Based
      • 5.3.1. Global cartilage repair/regeneration market for non-cell based, 2015 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Cartilage Repair/Regeneration Market - Type Segment Analysis
    • 6.1. Global cartilage repair/regeneration market: by type overview
      • 6.1.1. Global cartilage repair/regeneration market revenue share, by type,2018 and 2024
    • 6.2. Fibro Cartilage
      • 6.2.1. Global cartilage repair/regeneration market for fibro cartilage, 2015 - 2024 (USD Billion)
    • 6.3. Hyaline Cartilage
      • 6.3.1. Global cartilage repair/regeneration market for hyaline cartilage, 2015 - 2024 (USD Billion)
    • 6.4. Elastic Cartilage
      • 6.4.1. Global cartilage repair/regeneration market for elastic cartilage, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Cartilage Repair/Regeneration Market - Treatment Segment Analysis
    • 7.1. Global cartilage repair/regeneration market: by treatment overview
      • 7.1.1. Global cartilage repair/regeneration market revenue share, by treatment ,2018 and 2024
    • 7.2. Cartilage Replacement
      • 7.2.1. Global cartilage repair/regeneration market for cartilage replacement, 2015 - 2024 (USD Billion)
    • 7.3. Cartilage Repair
      • 7.3.1. Global cartilage repair/regeneration market for cartilage repair, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Cartilage Repair/Regeneration Market - End Use Segment Analysis
    • 8.1. Global cartilage repair/regeneration market: by end use overview
      • 8.1.1. Global cartilage repair/regeneration market revenue share, by end use,2018 and 2024
    • 8.2. Ambulatory Surgical Centers
      • 8.2.1. Global cartilage repair/regeneration market for diagnostic, 2015 - 2024 (USD Billion)
    • 8.3. Hospitals & Clinics
      • 8.3.1. Global cartilage repair/regeneration market for hospitals & clinics, 2015 - 2024 (USD Billion)
    • 8.4. Others
      • 8.4.1. Global cartilage repair/regeneration market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Global Cartilage repair/regeneration Market - Regional Segment Analysis
    • 9.1. Global cartilage repair/regeneration market: regional overview
      • 9.1.1. Global cartilage repair/regeneration market revenue share, by region,2018 and 2024
    • 9.2. North America
      • 9.2.1. North America cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
      • 9.2.2. North America cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.2.3. North America cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
      • 9.2.4. North America cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.2.5.2. The U.S. cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.2.5.3. The U.S. cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.2.5.4. The U.S. cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.2.6. Canada
        • 9.2.6.1. Canada cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.2.6.2. Canada cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.2.6.3. Canada cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.2.6.4. Canada cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
      • 9.3.2. Europe cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.3.3. Europe cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
      • 9.3.4. Europe cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.3.5. Germany
        • 9.3.5.1. Germany cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.3.5.2. Germany cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.5.3. Germany cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.3.5.4. Germany cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.3.6. U.K.
        • 9.3.6.1. U.K. cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.3.6.2. U.K. cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.6.3. U.K. cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.3.6.4. U.K. cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.3.7.2. France cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.7.3. France cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.3.7.4. France cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.3.8.2. Rest of Europe cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.8.3. Rest of Europe cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.3.8.4. Rest of Europe cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
      • 9.4.2. Asia Pacific cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.4.3. Asia Pacific cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
      • 9.4.4. Asia Pacific cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.4.5.2. China cartilage repair/regeneration market revenue, by treatment type, 2015 - 2024 (USD Billion)
        • 9.4.5.3. China cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.4.5.4. China cartilage repair/regeneration market revenue, by treatment type, 2015 - 2024 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.4.6.2. Japan cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.6.3. Japan cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.4.6.4. Japan cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.4.7.2. India cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.7.3. India cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.4.7.4. India cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024(USD Billion)
      • 9.5.2. Latin America cartilage repair/regeneration market revenue, by type, 2015 - 2024(USD Billion)
      • 9.5.3. Latin America cartilage repair/regeneration market revenue, by treatment , 2015 - 2024(USD Billion)
      • 9.5.4. Latin America cartilage repair/regeneration market revenue, by end use, 2015 - 2024(USD Billion)
      • 9.5.5. Latin America cartilage repair/regeneration market revenue, by care-setting, 2015 - 2024 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.5.6.2. Brazil cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.5.6.3. Brazil cartilage repair/regeneration market revenue, by treatment type, 2015 - 2024 (USD Billion)
        • 9.5.6.4. Brazil cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
        • 9.5.7.2. Rest of Latin America cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.5.7.3. Rest of Latin America cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
        • 9.5.7.4. Rest of Latin America cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa cartilage repair/regeneration market revenue, by treatment modality, 2015 - 2024 (USD Billion)
      • 9.6.2. The Middle East and Africa cartilage repair/regeneration market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.6.3. The Middle East and Africa cartilage repair/regeneration market revenue, by treatment , 2015 - 2024 (USD Billion)
      • 9.6.4. The Middle East and Africa cartilage repair/regeneration market revenue, by end use, 2015 - 2024 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Osiris Therapeutics, Inc
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Smith & Nephew PLC
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Vericel Corporation
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. AG Depuy Synthes
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Zimmer Biomet Holdings, Inc.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. B. Braun Melsungen AG
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Anika Therapeutics S. R. L
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Conmed Linvatec
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. RTI Surgical
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Arthrex, Inc.
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments

Methodology

Free Analysis

Smooth lining which acts as a joint lubricant and absorbs shock on the bone surface is called cartilage. As we get older or face any kind of traumatic injury, cartilage undergoes wear and tear and affects the loading of joints. Due to several drawbacks of the conventional methods used for the repairing of cartilage it has been replaced by the regenerative therapy which has gained its importance with emerging technology. Cartilage repair/regeneration is a type of regenerative therapy prominently used for the regeneration of damaged cartilage.

Increasing geriatric population has resulted in the increasing number of cartilage distortion problem because of old age, people are highly prone to cartilage damage mainly due to the reduction of lubricants over the course of time. According to the World Health Organization, the number of people of age 60 or above is estimated to be doubled by 2050, rising from 962 million in 2017 to 2.1 billion in 2050 globally. Moreover increasing road accidents under the influence of distorted roads, harsh weather conditions, reckless driving, etc. is furthermore propelling the growth of the cartilage repair/regeneration market. According to the statics published by the World Health Organization in 2016, around 1.25 million people died in road accidents worldwide. However, the high cost of treatment may pose a challenge to the cartilage repair/regeneration market. Nevertheless, growing awareness about advantages of the technology, advanced therapies, and treatment methodologies along with the prominent investment in research and development of cartilage repair/regeneration market across the globe are expected to act as driving factor for the cartilage repair/regeneration market in the near future.

Global Cartilage Repair Regeneration Market
 
The cartilage repair/regeneration market is divided by treatment modality, type, treatment, and end-use. Based on treatment modality, the cartilage repair/regeneration market has been segmented into cell-based and non-cell based. The cell-based segment is sub-segmented into growth factor technology, chondrocyte transplantation, and stem cells. The non-cell segment is sub-segmented into cell-free composites, tissue scaffolds, and stem cells. By treatment modality, cell-based treatment is estimated to hold the largest market value share attributed to the fact of long-term & effective results.

On the basis of treatment, the cartilage repair/regeneration market is segmented into cartilage replacement and cartilage repair. The cartilage replacement segment is sub-segmented into autologous chondrocyte implantation and osteochondral transplant. The cartilage repair segment is sub-segmented into cell-based cartilage resurfacing, microfracture, and non-surgical treatment.

By type segment, cartilage repair/regeneration market is categorized into fibrocartilage, hyaline cartilage, and elastic cartilage.
Based on end use, the cartilage repair/regeneration market is classified into ambulatory surgical centers, surgical centers, hospitals and clinics and others. Hospital & clinics segment hold maximum share and is expected to boost the market over the forecast period.

North America is anticipated to be the dominant region in the cartilage repair/regeneration market over the forecast period. Favorable government policies supporting the invasion of new and advanced therapies, development in the healthcare infrastructure, and research granted by the government and ruling authorities are expected to propel the growth of the market in this region. Europe is the second largest market followed by Asia Pacific. Large healthcare industry due to the large population base in the Asia Pacific region, especially India, China, and Japan is the significant accelerating factor for the growth of the cartilage repair/regeneration market in this region. Therefore, Asia Pacific is anticipated to show the fastest CAGR growth during the forecast period; whereas Latin America market is estimated to grow at a slow to moderate rate during the forecast period. The Middle East and Africa are also expected to cover the prominent market value share in the cartilage repair/regeneration market global market.

Some of the key players in cartilage repair/regeneration market include Osiris Therapeutics, Inc., Smith & Nephew Plc, Vericel Corporation, Depuy Synthes, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Anika Therapeutics S. R. L, Conmed Linvatec, RTI Surgical, Arthrex, Inc., etc. 

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social